Global Anti-Tumor Drugs Databank Market Report

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,000	100 Pages	Magna Intelligence	April, 2024	MAIN18749750

Best Price Guarantee
Price	from $2,000
Length	100 Pages
Publisher	Magna Intelligence
Published Date	April, 2024
SKU	MAIN18749750

Global Anti-Tumor Drugs Databank Market Report

The Anti-Tumor Drugs market was valued at $451,922.8 Million in 2020, and is projected to reach $976,438.3 Million by 2029 growing at a CAGR of 8.98% from 2021 to 2029. Chemotherapy segment is expected to be the highest contributor to this market, with $234,295.8 Million in 2020, and is anticipated to reach $496,893.9 Million by 2029, registering a CAGR of 8.76%. Hormonal Therapy segment is anticipated to reach $212,183.7 Million by 2029 with the highest CAGR of 10.19%. Chemotherapy and Immunotherapy segments collectively expected to account for about 73.3% share of the Anti-Tumor Drugs market in 2020, with the former constituting around 51.8% share. Hormonal Therapy and Immunotherapy segments are expected to witness significant growth rates at a CAGR of 10.19% and 9.06% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 41.1% in the overall Anti-Tumor Drugs market in 2020, and is anticipated to reach 43.3% by 2029.

1. Global Anti-Tumor Drugs Market, By Type: 1.1. Overview; 1.2. Chemotherapy; 1.2.1 Chemotherapy Market, By Region; 1.2.1.1 North America Chemotherapy Market, By Country; 1.2.1.2 Europe Chemotherapy Market, By Country; 1.2.1.3 Asia-Pacific Chemotherapy Market, By Country; 1.2.1.4 Rest of World Chemotherapy Market, By Country; 1.3. Hormonal Therapy; 1.3.1 Hormonal Therapy Market, By Region; 1.3.1.1 North America Hormonal Therapy Market, By Country; 1.3.1.2 Europe Hormonal Therapy Market, By Country; 1.3.1.3 Asia-Pacific Hormonal Therapy Market, By Country; 1.3.1.4 Rest of World Hormonal Therapy Market, By Country; 1.4. Immunotherapy; 1.4.1 Immunotherapy Market, By Region; 1.4.1.1 North America Immunotherapy Market, By Country; 1.4.1.2 Europe Immunotherapy Market, By Country; 1.4.1.3 Asia-Pacific Immunotherapy Market, By Country; 1.4.1.4 Rest of World Immunotherapy Market, By Country; 1.5. Other Types; 1.5.1 Other Types Market, By Region; 1.5.1.1 North America Other Types Market, By Country; 1.5.1.2 Europe Other Types Market, By Country; 1.5.1.3 Asia-Pacific Other Types Market, By Country; 1.5.1.4 Rest of World Other Types Market, By Country
2. Global Anti-Tumor Drugs Market, By Application: 2.1. Overview; 2.2. Lung Cancer; 2.2.1 Lung Cancer Market, By Region; 2.2.1.1 North America Lung Cancer Market, By Country; 2.2.1.2 Europe Lung Cancer Market, By Country; 2.2.1.3 Asia-Pacific Lung Cancer Market, By Country; 2.2.1.4 Rest of World Lung Cancer Market, By Country; 2.3. Other Applications; 2.3.1 Other Applications Market, By Region; 2.3.1.1 North America Other Applications Market, By Country; 2.3.1.2 Europe Other Applications Market, By Country; 2.3.1.3 Asia-Pacific Other Applications Market, By Country; 2.3.1.4 Rest of World Other Applications Market, By Country; 2.4. Stomach Cancer; 2.4.1 Stomach Cancer Market, By Region; 2.4.1.1 North America Stomach Cancer Market, By Country; 2.4.1.2 Europe Stomach Cancer Market, By Country; 2.4.1.3 Asia-Pacific Stomach Cancer Market, By Country; 2.4.1.4 Rest of World Stomach Cancer Market, By Country; 2.5. Breast Cancer; 2.5.1 Breast Cancer Market, By Region; 2.5.1.1 North America Breast Cancer Market, By Country; 2.5.1.2 Europe Breast Cancer Market, By Country; 2.5.1.3 Asia-Pacific Breast Cancer Market, By Country; 2.5.1.4 Rest of World Breast Cancer Market, By Country
3. Global Anti-Tumor Drugs Market, By Region: 3.1. Overview; 3.2. North America; 3.2.1 North America Anti-Tumor Drugs Market, By Type; 3.2.2 North America Anti-Tumor Drugs Market, By Application; 3.2.3 North America Anti-Tumor Drugs Market, By Country; 3.2.3.1 U.S.; 3.2.3.1.1 U.S. Anti-Tumor Drugs Market, By Type; 3.2.3.1.2 U.S. Anti-Tumor Drugs Market, By Application; 3.2.3.2 Canada; 3.2.3.2.1 Canada Anti-Tumor Drugs Market, By Type; 3.2.3.2.2 Canada Anti-Tumor Drugs Market, By Application; 3.2.3.3 Mexico; 3.2.3.3.1 Mexico Anti-Tumor Drugs Market, By Type; 3.2.3.3.2 Mexico Anti-Tumor Drugs Market, By Application; 3.3. Europe; 3.3.1 Europe Anti-Tumor Drugs Market, By Type; 3.3.2 Europe Anti-Tumor Drugs Market, By Application; 3.3.3 Europe Anti-Tumor Drugs Market, By Country; 3.3.3.1 Germany; 3.3.3.1.1 Germany Anti-Tumor Drugs Market, By Type; 3.3.3.1.2 Germany Anti-Tumor Drugs Market, By Application; 3.3.3.2 France; 3.3.3.2.1 France Anti-Tumor Drugs Market, By Type; 3.3.3.2.2 France Anti-Tumor Drugs Market, By Application; 3.3.3.3 U.K.; 3.3.3.3.1 U.K. Anti-Tumor Drugs Market, By Type; 3.3.3.3.2 U.K. Anti-Tumor Drugs Market, By Application; 3.3.3.4 Italy; 3.3.3.4.1 Italy Anti-Tumor Drugs Market, By Type; 3.3.3.4.2 Italy Anti-Tumor Drugs Market, By Application; 3.3.3.5 Spain; 3.3.3.5.1 Spain Anti-Tumor Drugs Market, By Type; 3.3.3.5.2 Spain Anti-Tumor Drugs Market, By Application; 3.3.3.6 Rest of Europe; 3.3.3.6.1 Rest of Europe Anti-Tumor Drugs Market, By Type; 3.3.3.6.2 Rest of Europe Anti-Tumor Drugs Market, By Application; 3.4. Asia-Pacific; 3.4.1 Asia-Pacific Anti-Tumor Drugs Market, By Type; 3.4.2 Asia-Pacific Anti-Tumor Drugs Market, By Application; 3.4.3 Asia-Pacific Anti-Tumor Drugs Market, By Country; 3.4.3.1 China; 3.4.3.1.1 China Anti-Tumor Drugs Market, By Type; 3.4.3.1.2 China Anti-Tumor Drugs Market, By Application; 3.4.3.2 India; 3.4.3.2.1 India Anti-Tumor Drugs Market, By Type; 3.4.3.2.2 India Anti-Tumor Drugs Market, By Application; 3.4.3.3 Japan; 3.4.3.3.1 Japan Anti-Tumor Drugs Market, By Type; 3.4.3.3.2 Japan Anti-Tumor Drugs Market, By Application; 3.4.3.4 Australia; 3.4.3.4.1 Australia Anti-Tumor Drugs Market, By Type; 3.4.3.4.2 Australia Anti-Tumor Drugs Market, By Application; 3.4.3.5 South Korea; 3.4.3.5.1 South Korea Anti-Tumor Drugs Market, By Type; 3.4.3.5.2 South Korea Anti-Tumor Drugs Market, By Application; 3.4.3.6 Rest of Asia; 3.4.3.6.1 Rest of Asia Anti-Tumor Drugs Market, By Type; 3.4.3.6.2 Rest of Asia Anti-Tumor Drugs Market, By Application; 3.5. Rest of World; 3.5.1 Rest of World Anti-Tumor Drugs Market, By Type; 3.5.2 Rest of World Anti-Tumor Drugs Market, By Application; 3.5.3 Rest of World Anti-Tumor Drugs Market, By Country; 3.5.3.1 Brazil; 3.5.3.1.1 Brazil Anti-Tumor Drugs Market, By Type; 3.5.3.1.2 Brazil Anti-Tumor Drugs Market, By Application; 3.5.3.2 South Africa; 3.5.3.2.1 South Africa Anti-Tumor Drugs Market, By Type; 3.5.3.2.2 South Africa Anti-Tumor Drugs Market, By Application; 3.5.3.3 GCC; 3.5.3.3.1 GCC Anti-Tumor Drugs Market, By Type; 3.5.3.3.2 GCC Anti-Tumor Drugs Market, By Application; 3.5.3.4 RoW Countries; 3.5.3.4.1 RoW Countries Anti-Tumor Drugs Market, By Type; 3.5.3.4.2 RoW Countries Anti-Tumor Drugs Market, By Application; RoW Countries Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD LIST OF TABLES; TABLE 1. Global Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD; TABLE 2. Chemotherapy Market Value, By Region, 2020-2029, Million USD; TABLE 3. North America Chemotherapy Market Value, By Country, 2020-2029, Million USD; TABLE 4. Europe Chemotherapy Market Value, By Country, 2020-2029, Million USD; TABLE 5. Asia-Pacific Chemotherapy Market Value, By Country, 2020-2029, Million USD; TABLE 6. Rest of World Chemotherapy Market Value, By Country, 2020-2029, Million USD; TABLE 7. Hormonal Therapy Market Value, By Region, 2020-2029, Million USD; TABLE 8. North America Hormonal Therapy Market Value, By Country, 2020-2029, Million USD; TABLE 9. Europe Hormonal Therapy Market Value, By Country, 2020-2029, Million USD; TABLE 10. Asia-Pacific Hormonal Therapy Market Value, By Country, 2020-2029, Million USD; TABLE 11. Rest of World Hormonal Therapy Market Value, By Country, 2020-2029, Million USD; TABLE 12. Immunotherapy Market Value, By Region, 2020-2029, Million USD; TABLE 13. North America Immunotherapy Market Value, By Country, 2020-2029, Million USD; TABLE 14. Europe Immunotherapy Market Value, By Country, 2020-2029, Million USD; TABLE 15. Asia-Pacific Immunotherapy Market Value, By Country, 2020-2029, Million USD; TABLE 16. Rest of World Immunotherapy Market Value, By Country, 2020-2029, Million USD; TABLE 17. Other Types Market Value, By Region, 2020-2029, Million USD; TABLE 18. North America Other Types Market Value, By Country, 2020-2029, Million USD; TABLE 19. Europe Other Types Market Value, By Country, 2020-2029, Million USD; TABLE 20. Asia-Pacific Other Types Market Value, By Country, 2020-2029, Million USD; TABLE 21. Rest of World Other Types Market Value, By Country, 2020-2029, Million USD; TABLE 22. Global Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD; TABLE 23. Lung Cancer Market Value, By Region, 2020-2029, Million USD; TABLE 24. North America Lung Cancer Market Value, By Country, 2020-2029, Million USD; TABLE 25. Europe Lung Cancer Market Value, By Country, 2020-2029, Million USD; TABLE 26. Asia-Pacific Lung Cancer Market Value, By Country, 2020-2029, Million USD; TABLE 27. Rest of World Lung Cancer Market Value, By Country, 2020-2029, Million USD; TABLE 28. Other Applications Market Value, By Region, 2020-2029, Million USD; TABLE 29. North America Other Applications Market Value, By Country, 2020-2029, Million USD; TABLE 30. Europe Other Applications Market Value, By Country, 2020-2029, Million USD; TABLE 31. Asia-Pacific Other Applications Market Value, By Country, 2020-2029, Million USD; TABLE 32. Rest of World Other Applications Market Value, By Country, 2020-2029, Million USD; TABLE 33. Stomach Cancer Market Value, By Region, 2020-2029, Million USD; TABLE 34. North America Stomach Cancer Market Value, By Country, 2020-2029, Million USD; TABLE 35. Europe Stomach Cancer Market Value, By Country, 2020-2029, Million USD; TABLE 36. Asia-Pacific Stomach Cancer Market Value, By Country, 2020-2029, Million USD; TABLE 37. Rest of World Stomach Cancer Market Value, By Country, 2020-2029, Million USD; TABLE 38. Breast Cancer Market Value, By Region, 2020-2029, Million USD; TABLE 39. North America Breast Cancer Market Value, By Country, 2020-2029, Million USD; TABLE 40. Europe Breast Cancer Market Value, By Country, 2020-2029, Million USD; TABLE 41. Asia-Pacific Breast Cancer Market Value, By Country, 2020-2029, Million USD; TABLE 42. Rest of World Breast Cancer Market Value, By Country, 2020-2029, Million USD; TABLE 43. Global Anti-Tumor Drugs Market Value, By Region, 2020-2029, Million USD; TABLE 44. North America Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD; TABLE 45. North America Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD; TABLE 46. North America Anti-Tumor Drugs Market Value, By Country, 2020-2029, Million USD; TABLE 47. U.S. Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD; TABLE 48. U.S. Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD; TABLE 49. Canada Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD; TABLE 50. Canada Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD; TABLE 51. Mexico Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD; TABLE 52. Mexico Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD; TABLE 53. Europe Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD; TABLE 54. Europe Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD; TABLE 55. Europe Anti-Tumor Drugs Market Value, By Country, 2020-2029, Million USD; TABLE 56. Germany Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD; TABLE 57. Germany Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD; TABLE 58. France Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD; TABLE 59. France Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD; TABLE 60. U.K. Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD; TABLE 61. U.K. Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD; TABLE 62. Italy Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD; TABLE 63. Italy Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD; TABLE 64. Spain Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD; TABLE 65. Spain Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD; TABLE 66. Rest of Europe Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD; TABLE 67. Rest of Europe Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD; TABLE 68. Asia-Pacific Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD; TABLE 69. Asia-Pacific Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD; TABLE 70. Asia-Pacific Anti-Tumor Drugs Market Value, By Country, 2020-2029, Million USD; TABLE 71. China Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD; TABLE 72. China Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD; TABLE 73. India Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD; TABLE 74. India Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD; TABLE 75. Japan Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD; TABLE 76. Japan Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD; TABLE 77. Australia Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD; TABLE 78. Australia Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD; TABLE 79. South Korea Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD; TABLE 80. South Korea Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD; TABLE 81. Rest of Asia Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD; TABLE 82. Rest of Asia Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD; TABLE 83. Rest of World Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD; TABLE 84. Rest of World Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD; TABLE 85. Rest of World Anti-Tumor Drugs Market Value, By Country, 2020-2029, Million USD; TABLE 86. Brazil Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD; TABLE 87. Brazil Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD; TABLE 88. South Africa Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD; TABLE 89. South Africa Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD; TABLE 90. GCC Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD; TABLE 91. GCC Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD; TABLE 92. RoW Countries Anti-Tumor Drugs Market Value, By Type, 2020-2029, Million USD; TABLE 93. RoW Countries Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD; RoW Countries Anti-Tumor Drugs Market Value, By Application, 2020-2029, Million USD